Veerabhadran Baladandayuthapani

Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial

Jason R. Westin, Fuliang Chu, Min Zhang et al. · The Lancet Oncology · 2013 · 528 citations · Full text

Lymphoid Neoplasia, Medicine, Immunology +10

Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial

Nathan Fowler, R. Eric Davis, Seema Rawal et al. · The Lancet Oncology · 2014 · 258 citations · Full text

Lymphoid Neoplasia, Medicine, Malignant Blood Disorder +5

Phase I Clinical Trial of Systemically Administered TUSC2(FUS1)-Nanoparticles Mediating Functional Gene Transfer in Humans

Charles Lu, David J. Stewart, J. Jack Lee et al. · PLoS ONE · 2012 · 181 citations · Full text

Ursolic Acid Inhibits Growth and Metastasis of Human Colorectal Cancer in an Orthotopic Nude Mouse Model by Targeting Multiple Cell Signaling Pathways: Chemosensitization with Capecitabine

Sahdeo Prasad, Vivek R. Yadav, Bokyung Sung et al. · Clinical Cancer Research · 2012 · 178 citations · Full text

Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma

Deborah J. Kuhn, Zuzana Berkova, Richard J. Jones et al. · Blood · 2012 · 172 citations · Full text